Given that the hs-cTnT is an important variable in the diagnosis of cardiac amyloidosis [10], it is not surprising that an increase in cardiac troponin I levels during tafamidis therapy was associated with a worse clinical course in our study. Here, TNNI3 is linked to cardiac amyloidosis.